BrightPath Biotherapeutics Co (TSE:4594) Pre-Tax Income : 円-1,166.18 Mil (TTM As of Sep. 2024)

BrightPath Biotherapeutics Co Pre-Tax Income Chart

BrightPath Biotherapeutics Co Annual Data
	Trend	Mar15	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22	Mar23	Mar24
Pre-Tax Income		Get a 7-Day Free Trial					-1,859.86	-1,717.21	-1,481.77	-1,483.73	-1,166.18

BrightPath Biotherapeutics Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Pre-Tax Income	Get a 7-Day Free Trial															-295.28	-257.69	-399.37	-213.84	-

Competitive Comparison of BrightPath Biotherapeutics Co's Pre-Tax Income

For the Biotechnology subindustry, BrightPath Biotherapeutics Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BrightPath Biotherapeutics Co's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BrightPath Biotherapeutics Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where BrightPath Biotherapeutics Co's Pre-Tax Income falls into.

BrightPath Biotherapeutics Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

BrightPath Biotherapeutics Co's Pretax Income for the fiscal year that ended in Mar. 2024 is calculated as

BrightPath Biotherapeutics Co's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円-1,166.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co  (TSE:4594) Pre-Tax Income Explanation

BrightPath Biotherapeutics Co's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

During the past 10 years, BrightPath Biotherapeutics Co's highest Pretax Margin was -49.71%. The lowest was -1619697.22%. And the median was -5411.93%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BrightPath Biotherapeutics Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of BrightPath Biotherapeutics Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.

BrightPath Biotherapeutics Co Business Description